WHO policy brief: Identifying common opportunistic infections among people with advanced HIV disease

Back to the "HIV and Co-Infections News" list
Tags:

Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining illness) poses a challenge to many countries globally and is responsible for significant mortality and morbidity among people living with HIV. In 2017, the World Health Organization (WHO) recommended a package of care for the prevention and management of advanced HIV disease. The package was composed of screening tests, diagnostics, prophylaxis, rapid antiretroviral therarpy initiation and enhanced adherence counselling.

The key screening and diagnostics tests are for the identification of tuberculosis, cryptococcal meningitis, histoplasmosis, and importantly, the assessment of CD4 cell count.

Supporting healthcare workers, national programmes as well as representatives of civil society in improving their understanding of how best to implement these interventions is critical for better uptake, thus improving outcomes for people living with HIV.

WHO released a policy brief summarizing key information on the use of these interventions, based on existing WHO guidelines and recommendations.

Access the policy brief here.

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.